FDA NDC Directory · JSON-LD · Markdown

ORFADIN

NDC 66658-204 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namenitisinone
Labeler / ManufacturerSwedish Orphan Biovitrum AB (publ)
Marketing categoryNew Drug Application (innovator) · App NDA206356
Dosage form / routeSUSPENSION · ORAL
Active ingredientsNITISINONE (4 mg/mL)
Marketing started20160601
Package count1

External sources

Source: openFDA. Public-domain (CC0).